Impact of Smoke Free Public Places (Smoke Free Cabs) on Cab Drivers in Mumbai

Compliance Clinical Trial

Official title:

Impact of Smoke Free Public Places (Smoke Free Cabs) on Cab Drivers in Mumbai, India

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02354638
• Other study ID #: TMHPOCAB2015
• Status: Completed
• Phase: N/A
• Start date: December 2014
• Est. completion date: April 2018

Study information

• Verified date: April 2018
• Source: Tata Memorial Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In addition to the passengers smoking inside the cab, the taxi drivers,are themselves addicted to smoking and/ or use of smokeless tobacco. Since tobacco is highly addictive, the cab drivers using tobacco need help in quitting. It is also necessary to raise the awareness of the cab drivers with respect to the hazards of tobacco and significance of the smoke free legislation.

It's been six years since the implementation of rules prohibiting smoking in public places and a re-look at the compliance to this regulation is necessary. The study will also help tobacco users to quit their habits. They will get screened for oral premalignant and malignant lesions.

Also, the cab drivers may pass on some effective messages regarding importance of keeping oneself away from tobacco, to the customers while commuting. In view of the above background, the current study is proposed to look at all these aspects.

The findings of the study will be certainly generating useful information with regards to lacunae in the existing system for appropriate implementation and for strengthening anti tobacco advocacy in our country.

Description:

AIM and OBJECTIVES:

1. To study the Knowledge, Attitudes and Practices (KAP) regarding tobacco and smoke free public places among cab drivers ferrying customers near Tata Memorial Hospital

2. To study the impact of smoke free public places with specific reference to smoke free cabs (on various factors such as number of customers, customer practices, health status, self practices, compliance etc.)

3. To understand their attitude towards smoke free cabs.

4. To educate them regarding hazards of tobacco and the need for smoke free cabs.

5. To invite the cab drivers using tobacco to avail the Preventive Oncology screening facilities and Tobacco cessation clinic at the Tata Memorial Hospital

6. To evaluate the compliance for availing the services

7. To study the post-intervention KAP regarding tobacco and smoke free public places

8. To determine the rate of oral pre-cancers and tobacco cessation after one year follow-up.

Methodology:

Design: Single arm interventional study

Step 1: Around 400 cab drivers in Mumbai will be enrolled after explaining the programme and obtaining informed consent. They will be interviewed with the help of a well structured questionnaire to collect information about their Knowledge, Attitudes and Practices (KAP) regarding tobacco, their attitudes and experiences regarding smoke free public places with specific reference to smoke free cabs.

Step 2: The cab drivers will be given detailed health education regarding hazards of tobacco and the need for smoke free cabs. They will be invited to participate in oral cancer screening at the Preventive Oncology (PO) screening clinic.

Step 3: The cab drivers will be again interviewed with the help of a well structured questionnaire to collect information of their post-intervention KAP regarding tobacco and smoke free public places.

Step 4: The cab drivers using tobacco will be invited to participate in the tobacco cessation programme at the TCC and will receive three monthly follow-up for one year. Various tobacco cessation interventions in the form of one to one counseling, focus group discussions, role plays, games etc. will be used. In addition they will be engaged in conveying messages about tobacco control and refraining from tobacco habit, to the customers while commuting. This will also reinforce their own commitment towards tobacco cessation.

Variables to be estimated:

1. the change in the baseline KAP

2. the perceptions and attitude of cab drivers regarding implementation of smoke free cab policy.

3. the results of oral cancer screening in the form of oral pre-cancers and cancers detected

4. the success of tobacco cessation programme in the form of self reported quit rates at the end of one year

5. reactions of the commuters and their own perceptions towards the no tobacco messages conveyed to the customers while traveling

Data Analysis:

Data entry will be done in the Department of Preventive Oncology, Tata Memorial Hospital using SPSS version 18. Checks for consistency, data safety and analysis will be carried out at regular intervals. Both descriptive and inferential statistics will be generated for describing variables under the study objectives.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 400
• Est. completion date: April 2018
• Est. primary completion date: April 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• 400 Cab drivers ferrying customers near Tata Memorial Hospital on a regular basis

Exclusion Criteria:

• Any Cab drivers outside the category as mentioned in the proposal

Related Conditions & MeSH terms

• Compliance

Intervention

Behavioral:
• Tobacco users
Various tobacco cessation interventions in the form of one to one counseling, focus group discussions, role plays, games etc. will be used in the tobacco users.

Drug:
• Pharmacotherapy
Pharmacotherapy will also be prescribed as per the need assessment consisting of: Nicotine Chewing Gums: Dose: 2 mg/4 mg, 10-15 pieces per day with maximum dose of 24 pieces/day depending on cravings.Total Duration: 12 weeks Duration of treatment: Higher dose for 4-6 weeks, with weaning till 2-3 months Nicotine Transdermal patches: Dose: 7 mg/10 mg/14 mg/21 mg -for 24-hours use. Total Duration: 12 weeks Duration of treatment: Higher strength patch for 2 weeks and depending on cravings will be gradually decreased till 4 weeks

Locations

Country	Name	City	State
India	Gauravi A. Mishra	Mumbai	Maharashtra

Sponsors (1)

Lead Sponsor	Collaborator
Tata Memorial Hospital

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Knowledge, Attitude & practice (change in the baseline KAP)	a) The	30 months
Secondary	Attitude regarding implementation of smoke free policy (perceptions and attitude of cab drivers)	b) The perceptions and attitude of cab drivers regarding implementation of smoke free cab policy.	30 months
Secondary	Oral cancer detection by oral screening	c)The results of oral cancer screening in the form of oral pre-cancers and cancers detected	30 months
Secondary	Quit rates (self reported quit rates)	d) The success of tobacco cessation programme in the form of self reported quit rates at the end of one year	30 months
Secondary	Reactions towards no tobacco messages (Reactions of the commuters and their own perceptions)	e) Reactions of the commuters and their own perceptions towards the no tobacco messages conveyed to the customers while traveling	30 months